首页 > 最新文献

Journal of Huazhong University of Science and Technology [Medical Sciences]最新文献

英文 中文
Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves' ophthalmopathy. 三维眶磁共振t2定位在Graves眼病患者评价中的应用。
Q Engineering Pub Date : 2017-12-01 Epub Date: 2017-12-21 DOI: 10.1007/s11596-017-1831-8
Kai Hou, Tao Ai, Wei-Kun Hu, Ban Luo, Yi-Ping Wu, Rong Liu

The clinical application of orbital magnetic resonance (MR) T2-mapping imaging in detecting the disease activity of Graves' ophthalmopathy (GO), and the predictive values of therapy response to intravenous glucocorticoid (ivGC) were investigated. Approved by the local institutional review board (IRB), 106 consecutive patients with GO were included in this prospective study. All subjects were divided into two groups according to the patients' clinical activity score (CAS): the CAS positive group (CAS ≥3) or the CAS negative group (CAS <3). T2 relaxation time of extraocular muscles (T2RT; ms) and the areas of four extra-ocular muscles (AEOMs; mm2) were measured by 3D T2-mapping MR sequence before and after methylprednisolone treatment, so as the CAS and some ophthalmic examinations including visual acuity, intra-ocular pressure, eyeball movement, diplopia and proptosis. In addition, 24 healthy volunteers were recruited as the control group. The mean T2RT and AEOMs in CAS positive group were higher than those in CAS negative group. Both CAS positive and negative groups had significantly higher mean T2RT and AEOMs than the control group (P<0.01). There was a positive correlation between T2RT and AEOMs values in GO patients, both of them had a positive correlation with CAS and the ophthalmic examinations. It was concluded that to evaluate the activity of GO, CAS was mostly related to inflammation symptoms of ocular surface, more than that, T2RT and AEOMs were also related to abnormal findings of the ophthalmic examinations including high ocular pressure, impaired eyeball movement, diplopia and proptosis. T2RT and AEOMs can reflex the inflammation state of ocular muscles better. CAS combined with 3D T2-mapping MR imaging could improve the sensitivity of detection of active GO so as the prediction and evaluation of the response to methylprednisolone treatment.

探讨眼眶磁共振(MR) t2定位成像在Graves眼病(GO)疾病活动性检测中的临床应用,以及对静脉注射糖皮质激素(ivGC)治疗反应的预测价值。经当地机构审查委员会(IRB)批准,106例连续的GO患者被纳入这项前瞻性研究。根据患者临床活动评分(CAS)将所有受试者分为两组:CAS阳性组(CAS≥3)或CAS阴性组(CAS 2)在甲强的松龙治疗前后采用3D T2-mapping MR序列测量CAS,并进行视力、眼压、眼球运动、复视、眼球突出等眼科检查。另外,还招募了24名健康志愿者作为对照组。CAS阳性组T2RT、AEOMs均值高于阴性组。CAS阳性组和阴性组的T2RT和AEOMs均值均显著高于对照组(P
{"title":"Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves' ophthalmopathy.","authors":"Kai Hou,&nbsp;Tao Ai,&nbsp;Wei-Kun Hu,&nbsp;Ban Luo,&nbsp;Yi-Ping Wu,&nbsp;Rong Liu","doi":"10.1007/s11596-017-1831-8","DOIUrl":"https://doi.org/10.1007/s11596-017-1831-8","url":null,"abstract":"<p><p>The clinical application of orbital magnetic resonance (MR) T2-mapping imaging in detecting the disease activity of Graves' ophthalmopathy (GO), and the predictive values of therapy response to intravenous glucocorticoid (ivGC) were investigated. Approved by the local institutional review board (IRB), 106 consecutive patients with GO were included in this prospective study. All subjects were divided into two groups according to the patients' clinical activity score (CAS): the CAS positive group (CAS ≥3) or the CAS negative group (CAS <3). T2 relaxation time of extraocular muscles (T2RT; ms) and the areas of four extra-ocular muscles (AEOMs; mm<sup>2</sup>) were measured by 3D T2-mapping MR sequence before and after methylprednisolone treatment, so as the CAS and some ophthalmic examinations including visual acuity, intra-ocular pressure, eyeball movement, diplopia and proptosis. In addition, 24 healthy volunteers were recruited as the control group. The mean T2RT and AEOMs in CAS positive group were higher than those in CAS negative group. Both CAS positive and negative groups had significantly higher mean T2RT and AEOMs than the control group (P<0.01). There was a positive correlation between T2RT and AEOMs values in GO patients, both of them had a positive correlation with CAS and the ophthalmic examinations. It was concluded that to evaluate the activity of GO, CAS was mostly related to inflammation symptoms of ocular surface, more than that, T2RT and AEOMs were also related to abnormal findings of the ophthalmic examinations including high ocular pressure, impaired eyeball movement, diplopia and proptosis. T2RT and AEOMs can reflex the inflammation state of ocular muscles better. CAS combined with 3D T2-mapping MR imaging could improve the sensitivity of detection of active GO so as the prediction and evaluation of the response to methylprednisolone treatment.</p>","PeriodicalId":15925,"journal":{"name":"Journal of Huazhong University of Science and Technology [Medical Sciences]","volume":"37 6","pages":"938-942"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11596-017-1831-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35682421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
RNAi-mediated human Nestin silence inhibits proliferation and migration of malignant melanoma cells by G1/S arrest via Akt-GSK3β-Rb pathway. rnai介导的人Nestin沉默通过Akt-GSK3β-Rb途径通过G1/S阻滞抑制恶性黑色素瘤细胞的增殖和迁移。
Q Engineering Pub Date : 2017-12-01 Epub Date: 2017-12-21 DOI: 10.1007/s11596-017-1824-7
Xu-Hui Yang, Tian Xia, Jie Zhang, Shao-Fen Yang, Hui-Xia Tang, Ting Tang, Zhi-Cheng Huang, Yue-Si Zhong, Feng He, Andy Peng Xiang

Human Nestin (hNestin) has been found to express in melanoma, and its expression is positively correlated with the advanced stage of melanoma. However, the precise role of hNestin in the development of melanoma has not been fully understood. The present study aimed to explore the role of hNestin in the proliferation and invasion of melanoma cells. The lentivirus vector carrying a short hairpin RNAs (shRNAs) targeting hNestin (hNestin-shRNA-LV) was stably infected into human melanoma cells UACC903, which expressed high levels of hNestin. The effects of hNestin knockdown on the proliferation, apoptosis, migration of melanoma cells and the related signaling pathways were investigated by immunofluorence, Western blotting and reverse transcription polymerase chain reaction (RT-PCR), respectively. The results showed that hNestin was expressed in most melanoma specimens and the melanoma cells studied. Knockdown of hNestin expression significantly inhibited the proliferation of melanoma cells, blocked the formation of cell colony, arrested cell cycle at G1/S stage and suppressed the activation of Akt and GSK3β. hNestin-silent cells also showed a sheet-like appearance with tight cell-cell adhesion, decreased membrane expression of N-cadherin and β-catenin, and attenuated migration. Furthermore, hNestin silence resulted in the inhibition of tumor growth in vivo. Our study indicates that hNestin knockdown suppresses the proliferation of melanoma cells, which might be through affecting Akt-GSK3β-Rb pathway-mediated G1/S arrest, and hNestin silence inhibits the migration by selectively modulating the expression of cell adhesion molecules in the process of epithelial-mesenchymal transition.

人类巢蛋白(Human Nestin, hNestin)已被发现在黑色素瘤中表达,其表达与黑色素瘤进展程度呈正相关。然而,hNestin在黑色素瘤发展中的确切作用尚未完全了解。本研究旨在探讨hNestin在黑色素瘤细胞增殖和侵袭中的作用。将携带短发夹rna (hNestin- shrna - lv)靶向hNestin的慢病毒载体稳定感染到表达高水平hNestin的人黑色素瘤细胞UACC903中。采用免疫荧光法、免疫印迹法和逆转录聚合酶链反应(RT-PCR)研究hNestin基因敲低对黑色素瘤细胞增殖、凋亡、迁移及相关信号通路的影响。结果显示,hNestin在大多数黑色素瘤标本和所研究的黑色素瘤细胞中均有表达。下调hNestin的表达可显著抑制黑色素瘤细胞的增殖,阻断细胞集落的形成,使细胞周期停留在G1/S期,抑制Akt和GSK3β的活化。hnesting沉默细胞呈片状,细胞间黏附紧密,N-cadherin和β-catenin的膜表达减少,迁移减弱。此外,hNestin沉默导致体内肿瘤生长受到抑制。我们的研究表明,hNestin敲低抑制黑色素瘤细胞的增殖可能是通过影响Akt-GSK3β-Rb途径介导的G1/S阻滞,而hNestin沉默则是通过选择性调节上皮-间质转化过程中细胞粘附分子的表达来抑制黑色素瘤细胞的迁移。
{"title":"RNAi-mediated human Nestin silence inhibits proliferation and migration of malignant melanoma cells by G<sub>1</sub>/S arrest via Akt-GSK3β-Rb pathway.","authors":"Xu-Hui Yang,&nbsp;Tian Xia,&nbsp;Jie Zhang,&nbsp;Shao-Fen Yang,&nbsp;Hui-Xia Tang,&nbsp;Ting Tang,&nbsp;Zhi-Cheng Huang,&nbsp;Yue-Si Zhong,&nbsp;Feng He,&nbsp;Andy Peng Xiang","doi":"10.1007/s11596-017-1824-7","DOIUrl":"https://doi.org/10.1007/s11596-017-1824-7","url":null,"abstract":"<p><p>Human Nestin (hNestin) has been found to express in melanoma, and its expression is positively correlated with the advanced stage of melanoma. However, the precise role of hNestin in the development of melanoma has not been fully understood. The present study aimed to explore the role of hNestin in the proliferation and invasion of melanoma cells. The lentivirus vector carrying a short hairpin RNAs (shRNAs) targeting hNestin (hNestin-shRNA-LV) was stably infected into human melanoma cells UACC903, which expressed high levels of hNestin. The effects of hNestin knockdown on the proliferation, apoptosis, migration of melanoma cells and the related signaling pathways were investigated by immunofluorence, Western blotting and reverse transcription polymerase chain reaction (RT-PCR), respectively. The results showed that hNestin was expressed in most melanoma specimens and the melanoma cells studied. Knockdown of hNestin expression significantly inhibited the proliferation of melanoma cells, blocked the formation of cell colony, arrested cell cycle at G<sub>1</sub>/S stage and suppressed the activation of Akt and GSK3β. hNestin-silent cells also showed a sheet-like appearance with tight cell-cell adhesion, decreased membrane expression of N-cadherin and β-catenin, and attenuated migration. Furthermore, hNestin silence resulted in the inhibition of tumor growth in vivo. Our study indicates that hNestin knockdown suppresses the proliferation of melanoma cells, which might be through affecting Akt-GSK3β-Rb pathway-mediated G<sub>1</sub>/S arrest, and hNestin silence inhibits the migration by selectively modulating the expression of cell adhesion molecules in the process of epithelial-mesenchymal transition.</p>","PeriodicalId":15925,"journal":{"name":"Journal of Huazhong University of Science and Technology [Medical Sciences]","volume":"37 6","pages":"895-903"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11596-017-1824-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35682016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Progress in the research on venous thromboembolism. 静脉血栓栓塞的研究进展。
Q Engineering Pub Date : 2017-12-01 Epub Date: 2017-12-21 DOI: 10.1007/s11596-017-1811-z
Zhen Zhang, Liang Tang, Yu Hu

Venous thromboembolism (VTE) is a common disease with high risk for death and recurrence and can severely impair patients' quality of life. Despite decades of study on this troublesome disease, there are still many unsolved problems in terms of pathogenesis, diagnosis and treatment. Hundreds of articles with various study methods and controversial research results are published every year. Thus it is crucial to keep track of reliable recent studies and articles on VTE in order to better understand it and to handle intricate related clinical events more reasonably. We reviewed high-qualified articles and guidelines from recent years and summarized VTE-related progresses in this review.

静脉血栓栓塞(Venous thromboembolism, VTE)是一种常见病,死亡和复发风险高,严重影响患者的生活质量。尽管对这一棘手的疾病进行了数十年的研究,但在发病机制、诊断和治疗方面仍有许多未解决的问题。每年都有数百篇研究方法各异、研究结果有争议的文章发表。因此,为了更好地理解静脉血栓栓塞,更合理地处理复杂的相关临床事件,跟踪可靠的最新研究和文章是至关重要的。我们回顾了近年来高质量的文章和指南,总结了vte相关的研究进展。
{"title":"Progress in the research on venous thromboembolism.","authors":"Zhen Zhang,&nbsp;Liang Tang,&nbsp;Yu Hu","doi":"10.1007/s11596-017-1811-z","DOIUrl":"https://doi.org/10.1007/s11596-017-1811-z","url":null,"abstract":"<p><p>Venous thromboembolism (VTE) is a common disease with high risk for death and recurrence and can severely impair patients' quality of life. Despite decades of study on this troublesome disease, there are still many unsolved problems in terms of pathogenesis, diagnosis and treatment. Hundreds of articles with various study methods and controversial research results are published every year. Thus it is crucial to keep track of reliable recent studies and articles on VTE in order to better understand it and to handle intricate related clinical events more reasonably. We reviewed high-qualified articles and guidelines from recent years and summarized VTE-related progresses in this review.</p>","PeriodicalId":15925,"journal":{"name":"Journal of Huazhong University of Science and Technology [Medical Sciences]","volume":"37 6","pages":"811-815"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11596-017-1811-z","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35682040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Reproductive outcomes in women with prior cesarean section undergoing in vitro fertilization: A retrospective case-control study. 既往剖宫产妇女体外受精的生殖结局:回顾性病例对照研究。
Q Engineering Pub Date : 2017-12-01 Epub Date: 2017-12-21 DOI: 10.1007/s11596-017-1828-3
Ya-Qin Wang, Tai-Lang Yin, Wang-Min Xu, Qian-Rong Qi, Xiao-Chen Wang, Jing Yang

The impact of prior cesarean section (CS) on the pregnancy and neonatal outcomes of in vitro fertilization and embryo transfer (IVF-ET) was investigated. A retrospective analysis was performed on 144 patients with prior CS between January 2013 and December 2015. The pregnancy, delivery, and neonatal outcomes of patients who had previous CS delivery and received IVF-ET were analyzed. The control group comprised 166 patients who had only previous vaginal delivery (VD) and received IVF-ET during the same period. The results showed that the basal follicle stimulating hormone level, estradiol level on human chorionic gonadotropin (hCG) day, gonadotrophin dosage, duration of stimulation, retrieved oocytes, fertilization rate, high-quality embryo rate, multiple birth rate, abortion rate and ectopic pregnancy rate had no significant difference between the two groups (P>0.05). The pregnancy rate (40.28% vs. 54.22%) and implantation rate (24.01% vs. 34.67%) were significantly lower (P<0.05), and the ratio of embryo difficulty transfer (9/144 vs. 0/166) was significantly higher in CS group than in VD group. The risk of pernicious placenta previa and postpartum hemorrhage in twin deliveries was significantly increased in CS group as compared with that in VD group (P<0.05), and gestational age and neonatal birth weight were significantly reduced in twin deliveries as compared with singleton deliveries in both groups (P<0.05). It was suggested that the existence of CS scar may impact embryo implantation and clinical pregnancy outcome, and increase the difficulty of ET. We should limit the number of transfer embryos to avoid multiple pregnancies and strengthen gestational supervision in patients with cesarean scar.

探讨既往剖宫产(CS)对体外受精和胚胎移植(IVF-ET)妊娠和新生儿结局的影响。对2013年1月至2015年12月144例既往CS患者进行回顾性分析。分析既往CS分娩并接受IVF-ET的患者的妊娠、分娩和新生儿结局。对照组包括166名患者,他们以前只有阴道分娩(VD),并在同一时期接受了IVF-ET。结果显示,两组小鼠基础促卵泡激素水平、雌二醇水平对人绒毛膜促性腺激素(hCG)日的影响、促性腺激素剂量、刺激持续时间、回收卵母细胞、受精率、优质胚胎率、多胎率、流产率和异位妊娠率差异均无统计学意义(P>0.05)。妊娠率(40.28% vs. 54.22%)和着床率(24.01% vs. 34.67%)均显著低于对照组(P
{"title":"Reproductive outcomes in women with prior cesarean section undergoing in vitro fertilization: A retrospective case-control study.","authors":"Ya-Qin Wang,&nbsp;Tai-Lang Yin,&nbsp;Wang-Min Xu,&nbsp;Qian-Rong Qi,&nbsp;Xiao-Chen Wang,&nbsp;Jing Yang","doi":"10.1007/s11596-017-1828-3","DOIUrl":"https://doi.org/10.1007/s11596-017-1828-3","url":null,"abstract":"<p><p>The impact of prior cesarean section (CS) on the pregnancy and neonatal outcomes of in vitro fertilization and embryo transfer (IVF-ET) was investigated. A retrospective analysis was performed on 144 patients with prior CS between January 2013 and December 2015. The pregnancy, delivery, and neonatal outcomes of patients who had previous CS delivery and received IVF-ET were analyzed. The control group comprised 166 patients who had only previous vaginal delivery (VD) and received IVF-ET during the same period. The results showed that the basal follicle stimulating hormone level, estradiol level on human chorionic gonadotropin (hCG) day, gonadotrophin dosage, duration of stimulation, retrieved oocytes, fertilization rate, high-quality embryo rate, multiple birth rate, abortion rate and ectopic pregnancy rate had no significant difference between the two groups (P>0.05). The pregnancy rate (40.28% vs. 54.22%) and implantation rate (24.01% vs. 34.67%) were significantly lower (P<0.05), and the ratio of embryo difficulty transfer (9/144 vs. 0/166) was significantly higher in CS group than in VD group. The risk of pernicious placenta previa and postpartum hemorrhage in twin deliveries was significantly increased in CS group as compared with that in VD group (P<0.05), and gestational age and neonatal birth weight were significantly reduced in twin deliveries as compared with singleton deliveries in both groups (P<0.05). It was suggested that the existence of CS scar may impact embryo implantation and clinical pregnancy outcome, and increase the difficulty of ET. We should limit the number of transfer embryos to avoid multiple pregnancies and strengthen gestational supervision in patients with cesarean scar.</p>","PeriodicalId":15925,"journal":{"name":"Journal of Huazhong University of Science and Technology [Medical Sciences]","volume":"37 6","pages":"922-927"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11596-017-1828-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35682418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 28
A modified surgical approach of hepatopancreatoduodenectomy for advanced gallbladder cancer: Report of two cases and literature review. 改良的肝胰十二指肠切除术治疗晚期胆囊癌2例报告并文献复习。
Q Engineering Pub Date : 2017-12-01 Epub Date: 2017-12-21 DOI: 10.1007/s11596-017-1817-6
Jian Wang, Zhan-Guo Zhang, Wan-Guang Zhang

Gallbladder cancer (GBC) is the most common cancer of the biliary tract, constituting 80%-95% of malignant biliary tract tumors. Surgical resection is currently regarded as the sole curative treatment for GBC. Hepatopancreatoduodenectomy (HPD) has been adopted to remove the advanced gallbladder tumor together with the infiltrated parts within the liver, lower biliary tract and the peripancreatic region of GBC patients. However, patients who underwent HPD were reported to have a distinctly higher postoperative morbidity (71.4%, ranging from 30.8% to 100%) and mortality (13.2%, ranging from 2.4% to 46.9%) than those given pancreatoduodenectomy (PD) alone. We present two patients with advanced GBC who underwent a modified surgical approach of HPD: PD with microwave ablation (MWA) of adjacent liver tissues and the technique of intraductal cooling of major bile ducts. No serious complications like bile leakage, pancreatic fistula, hemorrhage and organ dysfunction, etc. occurred in the two patients. They had a rapid recovery with postoperative hospital stay being 14 days. Application of this approach effectively eliminated tumor-infiltrated adjacent tissues, and maximally reduced the postoperative morbidity and mortality. This modified surgical method is secure and efficacious for the treatment of locally advanced GBC.

胆囊癌(GBC)是最常见的胆道肿瘤,占胆道恶性肿瘤的80%-95%。手术切除目前被认为是治疗GBC的唯一方法。GBC患者采用肝胰十二指肠切除术(HPD)切除晚期胆囊肿瘤及肝脏内浸润部位、胆道下段及胰周区。然而,与单独行胰十二指肠切除术(PD)的患者相比,行胰十二指肠切除术的患者术后发病率(71.4%,范围从30.8%到100%)和死亡率(13.2%,范围从2.4%到46.9%)明显更高。我们报告了两例晚期GBC患者,他们接受了一种改良的HPD手术方法:微波消融(MWA)邻近肝组织的PD和导管内冷却主要胆管技术。两例患者均未发生胆漏、胰瘘、出血、脏器功能障碍等严重并发症。术后住院14天,恢复迅速。应用该入路可有效消除肿瘤浸润的邻近组织,最大限度地降低术后发病率和死亡率。这种改良的手术方法对于局部晚期GBC的治疗是安全有效的。
{"title":"A modified surgical approach of hepatopancreatoduodenectomy for advanced gallbladder cancer: Report of two cases and literature review.","authors":"Jian Wang,&nbsp;Zhan-Guo Zhang,&nbsp;Wan-Guang Zhang","doi":"10.1007/s11596-017-1817-6","DOIUrl":"https://doi.org/10.1007/s11596-017-1817-6","url":null,"abstract":"<p><p>Gallbladder cancer (GBC) is the most common cancer of the biliary tract, constituting 80%-95% of malignant biliary tract tumors. Surgical resection is currently regarded as the sole curative treatment for GBC. Hepatopancreatoduodenectomy (HPD) has been adopted to remove the advanced gallbladder tumor together with the infiltrated parts within the liver, lower biliary tract and the peripancreatic region of GBC patients. However, patients who underwent HPD were reported to have a distinctly higher postoperative morbidity (71.4%, ranging from 30.8% to 100%) and mortality (13.2%, ranging from 2.4% to 46.9%) than those given pancreatoduodenectomy (PD) alone. We present two patients with advanced GBC who underwent a modified surgical approach of HPD: PD with microwave ablation (MWA) of adjacent liver tissues and the technique of intraductal cooling of major bile ducts. No serious complications like bile leakage, pancreatic fistula, hemorrhage and organ dysfunction, etc. occurred in the two patients. They had a rapid recovery with postoperative hospital stay being 14 days. Application of this approach effectively eliminated tumor-infiltrated adjacent tissues, and maximally reduced the postoperative morbidity and mortality. This modified surgical method is secure and efficacious for the treatment of locally advanced GBC.</p>","PeriodicalId":15925,"journal":{"name":"Journal of Huazhong University of Science and Technology [Medical Sciences]","volume":"37 6","pages":"855-860"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11596-017-1817-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35682009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Risk factors for acute kidney injury after orthotopic liver transplantation: A single-center data analysis. 原位肝移植后急性肾损伤的危险因素:单中心数据分析。
Q Engineering Pub Date : 2017-12-01 Epub Date: 2017-12-21 DOI: 10.1007/s11596-017-1818-5
Zhi-Qiang Zhou, Long-Chang Fan, Xu Zhao, Wei Xia, Ai-Lin Luo, Yu-Ke Tian, Xue-Ren Wang

Acute kidney injury (AKI) is a common complication following orthotopic liver transplantation (OLT) and is associated with increased morbidity and mortality. The aim of the current study was to determine the risk factors for AKI in patients undergoing OLT. A total of 103 patients who received OLT between January 2015 and May 2016 in Tongji Hospital, China, were retrospectively analyzed. Their demographic characteristics and perioperative parameters were collected, and AKI was diagnosed using 2012 Kidney Disease: Improving Global Outcomes (KDIGO) staging criteria. It was found that the incidence of AKI was 40.8% in this cohort and AKI was significantly associated with body mass index, urine volume, operation duration (especially > 480 min), and the postoperative use of vasopressors. It was concluded that relative low urine output, long operation duration, and the postoperative use of vasopressors are risk factors for AKI following OLT.

急性肾损伤(AKI)是原位肝移植(OLT)后常见的并发症,与发病率和死亡率增加有关。本研究的目的是确定接受OLT的患者发生AKI的危险因素。回顾性分析2015年1月至2016年5月在同济医院接受OLT治疗的103例患者。收集他们的人口学特征和围手术期参数,并使用2012肾脏疾病:改善全球预后(KDIGO)分期标准诊断AKI。研究发现,该队列中AKI的发生率为40.8%,AKI与体重指数、尿量、手术时间(尤其是> 480 min)和术后血管加压药物的使用有显著相关性。由此可见,相对低的尿量、较长的手术时间和术后使用血管加压药物是OLT后AKI的危险因素。
{"title":"Risk factors for acute kidney injury after orthotopic liver transplantation: A single-center data analysis.","authors":"Zhi-Qiang Zhou,&nbsp;Long-Chang Fan,&nbsp;Xu Zhao,&nbsp;Wei Xia,&nbsp;Ai-Lin Luo,&nbsp;Yu-Ke Tian,&nbsp;Xue-Ren Wang","doi":"10.1007/s11596-017-1818-5","DOIUrl":"https://doi.org/10.1007/s11596-017-1818-5","url":null,"abstract":"<p><p>Acute kidney injury (AKI) is a common complication following orthotopic liver transplantation (OLT) and is associated with increased morbidity and mortality. The aim of the current study was to determine the risk factors for AKI in patients undergoing OLT. A total of 103 patients who received OLT between January 2015 and May 2016 in Tongji Hospital, China, were retrospectively analyzed. Their demographic characteristics and perioperative parameters were collected, and AKI was diagnosed using 2012 Kidney Disease: Improving Global Outcomes (KDIGO) staging criteria. It was found that the incidence of AKI was 40.8% in this cohort and AKI was significantly associated with body mass index, urine volume, operation duration (especially > 480 min), and the postoperative use of vasopressors. It was concluded that relative low urine output, long operation duration, and the postoperative use of vasopressors are risk factors for AKI following OLT.</p>","PeriodicalId":15925,"journal":{"name":"Journal of Huazhong University of Science and Technology [Medical Sciences]","volume":"37 6","pages":"861-863"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11596-017-1818-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35682010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Efficacy of EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients harboring different types of EGFR mutations: A retrospective analysis. EGFR酪氨酸激酶抑制剂对不同类型EGFR突变的非小细胞肺癌患者的疗效:回顾性分析
Q Engineering Pub Date : 2017-12-01 Epub Date: 2017-12-21 DOI: 10.1007/s11596-017-1819-4
Hua-Li Liu, Guang Han, Min Peng, Yi-Ming Weng, Jing-Ping Yuan, Gui-Fang Yang, Jin-Ming Yu, Qi-Bin Song

With the development of molecular pathology, many types of epidermal growth factor receptor (EGFR) mutations have been identified. The efficacy of EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small cell lung cancer (NSCLC) patients with different types of EGFR mutations, especially in patients with single rare mutations or complex mutations (co-occurrence of two or more different mutations), has not been fully understood. This study aimed to examine the efficacy of EGFR-TKIs in NSCLC patients with different types of EGFR mutations. Clinical data of 809 NSCLC patients who harbored different types of EGFR mutations and treated from January 2012 to October 2016 at Renmin Hospital and Zhongnan Hospital, Wuhan, were retrospectively reviewed. The clinical characteristics of these patients and the efficacy of EGFR-TKIs were analyzed. Among these patients, 377 patients had only the EGFR del-19 mutation, 362 patients the EGFR L858R mutation in exon 21, 33 patients single rare mutations and 37 patients complex mutations. Among these 809 patients, 239 patients were treated with EGFR-TKIs. In all the 239 patients, the disease control rate (DCR) was 93.7% with two patients (0.2%) achieving complete response (CR), the median progression free survival (PFS) was 13.0 months (95% confidence interval [CI], 11.6-14.4 months), and the median overall survival (OS) was 55.0 months (95% CI, 26.3-83.7 months). Subgroup analysis revealed that the DCR in patients harboring single rare or complex mutations of EGFR was significantly lower than in those with del-19 or L858R mutation (P<0.001). Patients with classic mutations (del-19 and/or L858R mutations) demonstrated longer PFS (P<0.001) and OS (P=0.017) than those with uncommon mutations (single rare and/or complex mutations). Furthermore, the patients with single rare mutations had shorter median OS than in those with other mutations. Multivariate Cox regression analysis identified that the type of EGFR mutations was an independent risk factor for PFS (hazard ratio [HR]=0.308, 95% CI, 0.191-0.494, P<0.001) and OS (HR=0.221, 95% CI, 0.101-0.480, P<0.001). The results suggest that the single rare or complex EGFR mutations confer inferior efficacy of EGFR-TKIs treatment to the classic mutations. The prognosis of the single rare EGFR mutations is depressing. EGFR-TKIs may be not a good choice for NSCLC patients with single rare mutations of EGFR. Further studies in these patients with uncommon mutations (especially for the patients with single rare mutations) are needed to determine a better precision treatment.

随着分子病理学的发展,许多类型的表皮生长因子受体(EGFR)突变已被发现。EGFR酪氨酸激酶抑制剂(EGFR- tkis)对不同类型EGFR突变的非小细胞肺癌(NSCLC)患者,特别是单一罕见突变或复杂突变(两种或两种以上不同突变共同发生)患者的疗效尚未完全了解。本研究旨在探讨EGFR- tkis在不同类型EGFR突变的NSCLC患者中的疗效。回顾性分析2012年1月至2016年10月武汉市人民医院和中南医院收治的809例不同类型EGFR突变的非小细胞肺癌患者的临床资料。分析这些患者的临床特点及EGFR-TKIs的疗效。其中,仅有EGFR del-19突变的377例,21外显子有EGFR L858R突变的362例,单一罕见突变的33例,复杂突变的37例。在这809例患者中,239例患者接受了EGFR-TKIs治疗。239例患者中,疾病控制率(DCR)为93.7%,2例患者(0.2%)达到完全缓解(CR),中位无进展生存期(PFS)为13.0个月(95%可信区间[CI], 11.6 ~ 14.4个月),中位总生存期(OS)为55.0个月(95% CI, 26.3 ~ 83.7个月)。亚组分析显示,携带单一罕见或复杂EGFR突变的患者的DCR显著低于携带del-19或L858R突变的患者(P
{"title":"Efficacy of EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients harboring different types of EGFR mutations: A retrospective analysis.","authors":"Hua-Li Liu,&nbsp;Guang Han,&nbsp;Min Peng,&nbsp;Yi-Ming Weng,&nbsp;Jing-Ping Yuan,&nbsp;Gui-Fang Yang,&nbsp;Jin-Ming Yu,&nbsp;Qi-Bin Song","doi":"10.1007/s11596-017-1819-4","DOIUrl":"https://doi.org/10.1007/s11596-017-1819-4","url":null,"abstract":"<p><p>With the development of molecular pathology, many types of epidermal growth factor receptor (EGFR) mutations have been identified. The efficacy of EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small cell lung cancer (NSCLC) patients with different types of EGFR mutations, especially in patients with single rare mutations or complex mutations (co-occurrence of two or more different mutations), has not been fully understood. This study aimed to examine the efficacy of EGFR-TKIs in NSCLC patients with different types of EGFR mutations. Clinical data of 809 NSCLC patients who harbored different types of EGFR mutations and treated from January 2012 to October 2016 at Renmin Hospital and Zhongnan Hospital, Wuhan, were retrospectively reviewed. The clinical characteristics of these patients and the efficacy of EGFR-TKIs were analyzed. Among these patients, 377 patients had only the EGFR del-19 mutation, 362 patients the EGFR L858R mutation in exon 21, 33 patients single rare mutations and 37 patients complex mutations. Among these 809 patients, 239 patients were treated with EGFR-TKIs. In all the 239 patients, the disease control rate (DCR) was 93.7% with two patients (0.2%) achieving complete response (CR), the median progression free survival (PFS) was 13.0 months (95% confidence interval [CI], 11.6-14.4 months), and the median overall survival (OS) was 55.0 months (95% CI, 26.3-83.7 months). Subgroup analysis revealed that the DCR in patients harboring single rare or complex mutations of EGFR was significantly lower than in those with del-19 or L858R mutation (P<0.001). Patients with classic mutations (del-19 and/or L858R mutations) demonstrated longer PFS (P<0.001) and OS (P=0.017) than those with uncommon mutations (single rare and/or complex mutations). Furthermore, the patients with single rare mutations had shorter median OS than in those with other mutations. Multivariate Cox regression analysis identified that the type of EGFR mutations was an independent risk factor for PFS (hazard ratio [HR]=0.308, 95% CI, 0.191-0.494, P<0.001) and OS (HR=0.221, 95% CI, 0.101-0.480, P<0.001). The results suggest that the single rare or complex EGFR mutations confer inferior efficacy of EGFR-TKIs treatment to the classic mutations. The prognosis of the single rare EGFR mutations is depressing. EGFR-TKIs may be not a good choice for NSCLC patients with single rare mutations of EGFR. Further studies in these patients with uncommon mutations (especially for the patients with single rare mutations) are needed to determine a better precision treatment.</p>","PeriodicalId":15925,"journal":{"name":"Journal of Huazhong University of Science and Technology [Medical Sciences]","volume":"37 6","pages":"864-872"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11596-017-1819-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35682011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
'Outbreak Gold Standard' selection to provide optimized threshold for infectious diseases early-alert based on China Infectious Disease Automated-alert and Response System. 基于中国传染病自动预警和反应系统的“暴发金标准”选择为传染病预警提供优化阈值。
Q Engineering Pub Date : 2017-12-01 Epub Date: 2017-12-21 DOI: 10.1007/s11596-017-1814-9
Rui-Ping Wang, Yong-Gen Jiang, Gen-Ming Zhao, Xiao-Qin Guo, Engelgau Michael

The China Infectious Disease Automated-alert and Response System (CIDARS) was successfully implemented and became operational nationwide in 2008. The CIDARS plays an important role in and has been integrated into the routine outbreak monitoring efforts of the Center for Disease Control (CDC) at all levels in China. In the CIDARS, thresholds are determined using the "Mean+2SD‟ in the early stage which have limitations. This study compared the performance of optimized thresholds defined using the "Mean +2SD‟ method to the performance of 5 novel algorithms to select optimal "Outbreak Gold Standard (OGS)‟ and corresponding thresholds for outbreak detection. Data for infectious disease were organized by calendar week and year. The "Mean+2SD‟, C1, C2, moving average (MA), seasonal model (SM), and cumulative sum (CUSUM) algorithms were applied. Outbreak signals for the predicted value (Px) were calculated using a percentile-based moving window. When the outbreak signals generated by an algorithm were in line with a Px generated outbreak signal for each week, this Px was then defined as the optimized threshold for that algorithm. In this study, six infectious diseases were selected and classified into TYPE A (chickenpox and mumps), TYPE B (influenza and rubella) and TYPE C [hand foot and mouth disease (HFMD) and scarlet fever]. Optimized thresholds for chickenpox (P55), mumps (P50), influenza (P40, P55, and P75), rubella (P45 and P75), HFMD (P65 and P70), and scarlet fever (P75 and P80) were identified. The C1, C2, CUSUM, SM, and MA algorithms were appropriate for TYPE A. All 6 algorithms were appropriate for TYPE B. C1 and CUSUM algorithms were appropriate for TYPE C. It is critical to incorporate more flexible algorithms as OGS into the CIDRAS and to identify the proper OGS and corresponding recommended optimized threshold by different infectious disease types.

中国传染病自动预警响应系统(CIDARS)于2008年成功实施并在全国投入运行。CIDARS在中国各级疾病预防控制中心的常规疫情监测工作中发挥着重要作用,并已被纳入其中。在CIDARS中,阈值是在早期使用“平均值+2SD”确定的,这有局限性。本研究将使用“Mean +2SD”方法定义的优化阈值的性能与5种新算法的性能进行比较,以选择最优的“爆发金标准(OGS)”和相应的爆发检测阈值。传染病的数据按日历周和年组织。采用“Mean+2SD”、C1、C2、移动平均(MA)、季节模型(SM)和累积和(CUSUM)算法。使用基于百分位数的移动窗口计算预测值(Px)的爆发信号。当算法生成的爆发信号与每周生成的Px爆发信号一致时,该Px被定义为该算法的优化阈值。本研究选取6种传染病,将其分为A型(水痘和腮腺炎)、B型(流感和风疹)和C型(手足口病和猩红热)。确定了水痘(P55)、腮腺炎(P50)、流感(P40、P55和P75)、风疹(P45和P75)、手足口病(P65和P70)和猩红热(P75和P80)的最佳阈值。C1、C2、CUSUM、SM和MA算法适用于a型。6种算法均适用于b型。C1和CUSUM算法适用于c型。关键是要将更灵活的OGS算法纳入CIDRAS,并根据不同的传染病类型确定合适的OGS和相应的推荐优化阈值。
{"title":"'Outbreak Gold Standard' selection to provide optimized threshold for infectious diseases early-alert based on China Infectious Disease Automated-alert and Response System.","authors":"Rui-Ping Wang,&nbsp;Yong-Gen Jiang,&nbsp;Gen-Ming Zhao,&nbsp;Xiao-Qin Guo,&nbsp;Engelgau Michael","doi":"10.1007/s11596-017-1814-9","DOIUrl":"https://doi.org/10.1007/s11596-017-1814-9","url":null,"abstract":"<p><p>The China Infectious Disease Automated-alert and Response System (CIDARS) was successfully implemented and became operational nationwide in 2008. The CIDARS plays an important role in and has been integrated into the routine outbreak monitoring efforts of the Center for Disease Control (CDC) at all levels in China. In the CIDARS, thresholds are determined using the \"Mean+2SD‟ in the early stage which have limitations. This study compared the performance of optimized thresholds defined using the \"Mean +2SD‟ method to the performance of 5 novel algorithms to select optimal \"Outbreak Gold Standard (OGS)‟ and corresponding thresholds for outbreak detection. Data for infectious disease were organized by calendar week and year. The \"Mean+2SD‟, C1, C2, moving average (MA), seasonal model (SM), and cumulative sum (CUSUM) algorithms were applied. Outbreak signals for the predicted value (Px) were calculated using a percentile-based moving window. When the outbreak signals generated by an algorithm were in line with a Px generated outbreak signal for each week, this Px was then defined as the optimized threshold for that algorithm. In this study, six infectious diseases were selected and classified into TYPE A (chickenpox and mumps), TYPE B (influenza and rubella) and TYPE C [hand foot and mouth disease (HFMD) and scarlet fever]. Optimized thresholds for chickenpox (P<sub>55</sub>), mumps (P<sub>50</sub>), influenza (P<sub>40</sub>, P<sub>55</sub>, and P<sub>75</sub>), rubella (P<sub>45</sub> and P<sub>75</sub>), HFMD (P<sub>65</sub> and P<sub>70</sub>), and scarlet fever (P<sub>75</sub> and P<sub>80</sub>) were identified. The C1, C2, CUSUM, SM, and MA algorithms were appropriate for TYPE A. All 6 algorithms were appropriate for TYPE B. C1 and CUSUM algorithms were appropriate for TYPE C. It is critical to incorporate more flexible algorithms as OGS into the CIDRAS and to identify the proper OGS and corresponding recommended optimized threshold by different infectious disease types.</p>","PeriodicalId":15925,"journal":{"name":"Journal of Huazhong University of Science and Technology [Medical Sciences]","volume":"37 6","pages":"833-841"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11596-017-1814-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35682044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Video-assisted thoracoscopic surgery for the treatment of mediastinal lymph node tuberculous abscesses. 电视胸腔镜手术治疗纵隔淋巴结结核性脓肿。
Q Engineering Pub Date : 2017-12-01 Epub Date: 2017-12-21 DOI: 10.1007/s11596-017-1816-7
Tao Zuo, Feng-Yun Gong, Bao-Jun Chen, Zheng-Yi Ni, Ding-Yu Zhang

The mediastinal lymph node tuberculous abscesses (MLNTAs) are secondary to mediastinal tuberculous lymphadenitis. Surgical excision is often required when cold abscesses form. This study was aimed to examine video-assisted thoracoscopic surgery (VATS) for the treatment of MLNTA. Clinical data of 16 MLNTA patients who were treated in our hospital between December 1, 2013 and December 1, 2015 were retrospectively analyzed. All of the patients underwent the radical debridement and drainage of abscesses, and intrathoracic lesions were removed by VATS. They were also administered the intensified anti-tuberculosis treatment (ATT), and engaged in normal physical activity and follow-up for 3 to 6 months. The results showed that VATS was successfully attempted in all of the 16 MLNTA patients and they all had good recovery. Two patients developed complications after surgery, with one patient developing recurrent laryngeal nerve injury, and the other reporting poor wound healing. It was concluded that VATS is easy to perform, and safe, and has high rates of success and relatively few side-effects when used to treat MLNTA.

纵隔淋巴结结核性脓肿(MLNTAs)继发于纵隔结核性淋巴结炎。当形成冷脓肿时,通常需要手术切除。本研究旨在探讨视频胸腔镜手术(VATS)对MLNTA的治疗效果。回顾性分析2013年12月1日至2015年12月1日在我院治疗的16例MLNTA患者的临床资料。所有患者均行根治性清创及脓肿引流术,并行VATS切除胸内病变。同时给予强化抗结核治疗(ATT),进行正常体育活动,随访3 ~ 6个月。结果16例MLNTA患者均成功尝试VATS,且均恢复良好。2例患者术后出现并发症,其中1例出现喉返神经损伤,另1例报告伤口愈合不良。结论:VATS治疗MLNTA操作简单,安全,成功率高,副作用相对较少。
{"title":"Video-assisted thoracoscopic surgery for the treatment of mediastinal lymph node tuberculous abscesses.","authors":"Tao Zuo,&nbsp;Feng-Yun Gong,&nbsp;Bao-Jun Chen,&nbsp;Zheng-Yi Ni,&nbsp;Ding-Yu Zhang","doi":"10.1007/s11596-017-1816-7","DOIUrl":"https://doi.org/10.1007/s11596-017-1816-7","url":null,"abstract":"<p><p>The mediastinal lymph node tuberculous abscesses (MLNTAs) are secondary to mediastinal tuberculous lymphadenitis. Surgical excision is often required when cold abscesses form. This study was aimed to examine video-assisted thoracoscopic surgery (VATS) for the treatment of MLNTA. Clinical data of 16 MLNTA patients who were treated in our hospital between December 1, 2013 and December 1, 2015 were retrospectively analyzed. All of the patients underwent the radical debridement and drainage of abscesses, and intrathoracic lesions were removed by VATS. They were also administered the intensified anti-tuberculosis treatment (ATT), and engaged in normal physical activity and follow-up for 3 to 6 months. The results showed that VATS was successfully attempted in all of the 16 MLNTA patients and they all had good recovery. Two patients developed complications after surgery, with one patient developing recurrent laryngeal nerve injury, and the other reporting poor wound healing. It was concluded that VATS is easy to perform, and safe, and has high rates of success and relatively few side-effects when used to treat MLNTA.</p>","PeriodicalId":15925,"journal":{"name":"Journal of Huazhong University of Science and Technology [Medical Sciences]","volume":"37 6","pages":"849-854"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11596-017-1816-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35682046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Acetyl-L-carnitine: An effective antioxidant against cryo-damage on human spermatozoa with asthenospermia. 乙酰左旋肉碱:抗弱精子症患者精子低温损伤的有效抗氧化剂。
Q Engineering Pub Date : 2017-12-01 Epub Date: 2017-12-21 DOI: 10.1007/s11596-017-1827-4
Yu-Jie Zou, Jing Yang, Shuo Chang, Wang-Ming Xu, Tai-Lang Yin, Wen Long

A variety of natural and artificial cryoprotectant extenders have been explored to enhance sperm recovery following cryopreservation-thawing process. The current investigation is aimed at evaluating the effect of acetyl-L-carnitine on human spermatozoa and reactive species oxygen (ROS) level after freezing-thawing process. The spermatozoa were collected from 35 male patients diagnosed as having asthenospermia. The cryopreservation of human spermatozoa treated with acetyl-L-carnitine at different concentrations (group B: 2.5 mmol/L, group C: 7.5 mmol/L, group D: 15 mmol/L) was compared with control (group A: no acetyl-L-carnitine given). For the frozen-thawed spermatozoa, the viability, motility and DNA integrity were measured by comet assay, acrosome integrity by FITC-PNA staining and ROS level was determined in each group. The results showed that there were no significant differences in motility and viability between group A and group B, while the motility and viability of spermatozoa in group C and group D were significantly increased as compared with those in group A. As compared with group A, the values for DNA integrity parameters including comet rate (CR), tail DNA percentage (TD), tail length (TL) and Oliver tail moment (OTM) were significantly reduced in group C and group D. Group C and group D also displayed a higher proportion of intact acrosome than group A. No significant difference in ROS level was found between group A and group B, while with the increase in acetyl-L-carnitine concentration, the ROS level in groups C and D was significantly reduced as compared with that in group A. In conclusion, acetyl-L-carnitine at a concentration of 7.5 mmol/L is an effective antioxidant against cryo-damage on post-thawed human spermatozoa.

各种天然的和人工的冷冻保护剂已经被探索,以提高精子在冷冻解冻过程中的恢复。本研究旨在评价乙酰左旋肉碱对人精子冻融过程中活性氧(ROS)水平的影响。收集35例诊断为弱精子症的男性患者的精子。将不同浓度乙酰左旋肉碱(B组:2.5 mmol/L, C组:7.5 mmol/L, D组:15 mmol/L)处理的人精子冷冻保存与对照组(A组:未给予乙酰左旋肉碱)进行比较。冻融后各组精子活力、活力和DNA完整性采用彗星法测定,顶体完整性采用FITC-PNA染色法测定,ROS水平测定。结果表明,A组和B组之间精子活力和活力无显著差异,而C组和D组精子活力和活力显著高于A组。与A组相比,DNA完整性参数包括彗星率(CR)、尾DNA百分比(TD)、C组和D组的尾长(TL)和奥利弗尾矩(OTM)均显著降低,C组和D组的完整顶体比例也高于a组。a组和B组之间ROS水平无显著差异,但随着乙酰左旋肉碱浓度的增加,C组和D组的ROS水平与a组相比显著降低。浓度为7.5 mmol/L的乙酰左旋肉碱是一种有效的抗解冻后人精子冷冻损伤的抗氧化剂。
{"title":"Acetyl-L-carnitine: An effective antioxidant against cryo-damage on human spermatozoa with asthenospermia.","authors":"Yu-Jie Zou,&nbsp;Jing Yang,&nbsp;Shuo Chang,&nbsp;Wang-Ming Xu,&nbsp;Tai-Lang Yin,&nbsp;Wen Long","doi":"10.1007/s11596-017-1827-4","DOIUrl":"https://doi.org/10.1007/s11596-017-1827-4","url":null,"abstract":"<p><p>A variety of natural and artificial cryoprotectant extenders have been explored to enhance sperm recovery following cryopreservation-thawing process. The current investigation is aimed at evaluating the effect of acetyl-L-carnitine on human spermatozoa and reactive species oxygen (ROS) level after freezing-thawing process. The spermatozoa were collected from 35 male patients diagnosed as having asthenospermia. The cryopreservation of human spermatozoa treated with acetyl-L-carnitine at different concentrations (group B: 2.5 mmol/L, group C: 7.5 mmol/L, group D: 15 mmol/L) was compared with control (group A: no acetyl-L-carnitine given). For the frozen-thawed spermatozoa, the viability, motility and DNA integrity were measured by comet assay, acrosome integrity by FITC-PNA staining and ROS level was determined in each group. The results showed that there were no significant differences in motility and viability between group A and group B, while the motility and viability of spermatozoa in group C and group D were significantly increased as compared with those in group A. As compared with group A, the values for DNA integrity parameters including comet rate (CR), tail DNA percentage (TD), tail length (TL) and Oliver tail moment (OTM) were significantly reduced in group C and group D. Group C and group D also displayed a higher proportion of intact acrosome than group A. No significant difference in ROS level was found between group A and group B, while with the increase in acetyl-L-carnitine concentration, the ROS level in groups C and D was significantly reduced as compared with that in group A. In conclusion, acetyl-L-carnitine at a concentration of 7.5 mmol/L is an effective antioxidant against cryo-damage on post-thawed human spermatozoa.</p>","PeriodicalId":15925,"journal":{"name":"Journal of Huazhong University of Science and Technology [Medical Sciences]","volume":"37 6","pages":"915-921"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11596-017-1827-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35682417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
期刊
Journal of Huazhong University of Science and Technology [Medical Sciences]
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1